Peregrine Asset Advisers’s Novartis NVS Stock Holding History

Peregrine Asset Advisers’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-3,683	Closed	-$267K	–	119
2018 Q1	$267K	Hold	3,683	–	–	0.18%	76
2017 Q4	$277K	Hold	3,683	–	–	0.14%	81
2017 Q3	$283K	Buy	+3,683	New	+$278K	0.15%	66
2015 Q4	–	Sell	-2,567	Closed	-$211K	–	99
2015 Q3	$211K	Hold	2,567	–	–	0.22%	78
2015 Q2	$226K	Buy	+2,567	New	+$235K	0.17%	92
2015 Q1	–	Sell	-2,567	Closed	-$213K	–	141
2014 Q4	$213K	Hold	2,567	–	–	0.15%	109
2014 Q3	$216K	Buy	+2,567	New	+$208K	0.18%	102

Other funds holding NVS

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BBHC

Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Peregrine Asset Advisers's NVS Position: Q2 2018 in Review

Peregrine Asset Advisers sold out of Novartis (NVS) in Q2 2018, closing a stake of 3,683 shares — an estimated $267K sold.

Peregrine Asset Advisers first reported a position in NVS in Q3 2014 and held it in 7 quarters. The position peaked at $283K in Q3 2017. 987 funds tracked by Wall St. Rank hold NVS as of Q2 2018.

Peregrine Asset Advisers reported no remaining Novartis position as of Q2 2018 after selling out during the quarter.
Peregrine Asset Advisers sold 3,683 Novartis shares in Q2 2018, an estimated $267K.
Peregrine Asset Advisers first reported a position in Novartis in Q3 2014 and held it in 7 quarters.
Peregrine Asset Advisers's Novartis position peaked at $283K in Q3 2017.
987 funds tracked by Wall St. Rank held Novartis as of Q2 2018.

Based on Peregrine Asset Advisers's 13F filing for Q2 2018, filed 14 Aug 2018.